Clariant

MEVOPUR® offers antimicrobial options for medical devices

  • New formulations extend the MEVOPUR® range with MedX antimicrobial additives
  • Avoidance of secondary antimicrobial coating operation supports manufacturing productivity

Muttenz, February 28, 2012 - Clariant’s MEVOPUR® masterbatches now incorporate the newly introduced MedX silver product series from SANITIZED AG, extending the antimicrobial options for the medical device market. Supported by data on both the antimicrobial and polymers incorporating MEVOPUR antimicrobial masterbatch range, Clariant’s extended line supports streamlined development of medical devices needing the functional benefits of antimicrobials.

Clariant has laid the groundwork for our customers by developing data packages that can support regulatory notifications and filings, as well as reduce the time and costs associated with the product development stage. Our technical expertise can help find the right MEVOPUR package for your needs.

Clariant’s MEVOPUR masterbatches offer manufacturers the latest anti-microbial agents incorporated into the selected polymer carrier according to the final customer’s application requirements under Clariant’s ISO13485 quality system; in line with Clariant’s Controlled, Consistent, Compliant approach for the medical and pharmaceutical sectors.

Incorporating the antimicrobial protection directly in the polymer removes the need for device manufacturers to undertake a secondary antimicrobial coating operation on their medical device, with the associated cost and validation processes that are required. In addition it reduces the risk associated with delamination of the coating. The in-built antimicrobial function can be combined with other functionality. For example, in catheter designs Clariant proposes that the antimicrobial functionality can be incorporated into a multi-layer structure including an identifying color, radiopacity and friction reduction.

Main application areas for the MEVOPUR antimicrobial masterbatches are catheters, endoscopes and surgical instruments, and preservative-free pharmaceutical packaging solutions. Clariant can combine pigments into the masterbatch or maintain transparency levels depending on the application.

The MEVOPUR line furthers Clariant’s commitment to the medical and pharmaceutical industries. Today’s hospital environment is challenging. The MEVOPUR line offers customer one more way to meet those challenges.

Reader enquiries

Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland

+41 61 469 6742

www.clariant.com

@clariant

Clariant

ClariantInternational

clariant_international


Notes for editors


news.clariant.com

Clariant is an internationally active specialty chemical company, based in Muttenz near Basel. The group owns over 100 companies worldwide and employed 22 149 employees on December 31, 2011. In the financial year 2011, Clariant produced a turnover of CHF 7.4 billion. Clariant is divided into eleven business units: Additives; Catalysis & Energy; Emulsions, Detergents & Intermediates; Functional Materials; Industrial & Consumer Specialties; Leather Services; Masterbatches; Oil & Mining Services; Paper Specialties; Pigments; Textile Chemicals.

Clariant focuses on creating value by investing in future profitable and sustainable growth, which is based on four strategic pillars: Improving profitability, innovation as well as research and development, dynamic growth in emerging markets, and optimizing the portfolio through complementary acquisitions or divestments.

MEVOPUR is a registered trademark of Clariant.

Editorial enquiries

Stefanie NehlsenStefanie Nehlsen
Clariant International Ltd

+41 61 469 63 63

stefanie.nehlsen@​clariant.com

Josina van der VeldenJosina van der Velden
EMG

+31 164 317 014

jvandervelden@​emg-marcom.com

 

Share

 

More news from